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Background: We analyzed the impact associated with an intervention based on process control and performance
feedback to decrease central line-associated bloodstream infection (CLABSI) rates.
This study was conducted from March 2011 to September 2012 in five adult intensive care units (ICU) located in
two Belgian tertiary hospitals A and B, with a total of 53 beds.
Methods: This study was divided in three phases: P1 (baseline), P2 (intervention) and P3 (post intervention).
During P2, external monitoring of five central venous catheters (CVC) care critical processes and monthly reporting
(meetings and feedbacks reports posted) of performance indicators (CLABSI rate, CVC utilization ratio, compliance
rate with each care process, and insertion site) to ICU workers were performed. The external monitoring of process
measures was assessed by the same trained research nurse.
A Poisson regression analysis was used to compare CLABSI incidence density rate per phase. Statistical significance
was achieved with 2-sided p-value of <0.05. For the analysis, we separated the five ICU in hospital A and B when
appropriate.
Results: Significantly improved total mean compliance was achieved for hand hygiene, CVC handling and CVC
dressing. CLABSI rate declined from 4.00 (95% confidence interval (CI): 1.94-6.06) to 1.81 (0.46-3.17) per 1,000 CVC-
days in P2 with an incidence rate ratio (IRR) of 0.49 (0.24-0.98, p = 0.043). A better response was observed in hospital
A where the nurse participation at the monthly meeting was significantly higher than in hospital B (p < 0.001) as
the percentage of feedbacks reports posted in ICU (p < 0.001). The decline in the CLABSI rate observed during P2
in comparison with P1 was independent of the insertion site (femoral or non-femoral; p = 0.054). The overall CLABSI
rate increased to 2.73 (1.17-4.29) per 1,000 CVC-days with IRR of 0.67 (0.36-1.26, p = 0.212) in P3 compared to P1,
but a high nursing turnover was observed in both hospitals.
Conclusions: Our intervention focused on external auditing and performance feedback resulted in significant
reduction in rates of CLABSI. Investigation continues regarding the most effective way to sustain CLABSI prevention
practices and to improve the culture of safety in healthcare.
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Bloodstream infections associated with the insertion and
maintenance of central venous catheters (CVC) are the
most common cause of health care-associated infections
in intensive-care units (ICU) [1] and result in significant
morbidity, prolonged length of stay, and excess health-
care costs [2].
Prevention of central line-associated bloodstream infec-
tion (CLABSI) remains a major issue for patient safety
and costs. In fact, the CLABSI rate is proposed as an indi-
cator of quality of care in ICU in several countries. Studies
have shown that education and training of ICU health
care workers (HCW) concerning CVC care is efficient in
preventing CLABSI. Interventions focusing primarily on
central-line insertion procedures, emphasized staff educa-
tion, compliance to basic hygiene, and timely removal of
CVC have been associated with substantial reductions in
CLABSI rates [3-9]. Few studies have included the evalu-
ation of post-insertion care [10-13].
Moreover, the prevention of CLABSI is a team effort
involving all categories of HCW. Providing feedback on
surveillance data to ICU staff has been associated with a
reduced rate of hospital-acquired infections [14]. Such
feedback is a useful complement to other strategies par-
ticularly feedback regarding adherence to good practices
of CVC care [8,15,16]. The published CLABSI guidelines
provide recommendations for implementing a checklist
to ensure compliance with evidence-based practices and
for empowering nurses to ensure compliance with the
checklist (self-report method) [17].
The aim of this prospective interventional study was
to measure the added effectiveness of monitoring by an
external infection control team and continuous feedback
regarding performance indicators to decrease CLABSI
rates. The secondary objective was to evaluate the sus-
tainability of the project when discontinuing monitoring.
Methods
Study design
This multicenter quasi-experimental study was conducted
in five adult ICUs, designated ICU A1 (12 beds), A2 (12
beds), A3 (9 beds), B1 (10 beds) and B2 (10 beds), located
in two tertiary hospitals A (853 beds) and B (509 beds) in
Brussels, Belgium. Each ICU had mixed (medical and
surgical) intensive-care beds with a separate ICU team
(nurses and physicians). Before the beginning of the study,
no surveillance data on the CLABSI rate or systematic re-
cording of CVC-days was performed.
Study phase
The study was performed from March 2011 to September
2012 in 3 phases: a pre-intervention phase (Phase (P)
1), from March 2011 to August 2011, an intervention
phase (P2), from September 2011 to February 2012 anda post-intervention phase (P3), from March 2012 to
September 2012.
Study setting
Written policies and procedures that incorporated all as-
pects of the CVC care, maintenance and insertion pro-
cesses were available to ICU staff. CVC kits that contained
all the supplies necessary to comply with the sterile pro-
cedure for CVC placement were available in each ICU.
Lines were placed by attending physicians using an aseptic
technique and avoiding the femoral vein for CVC inser-
tion. The local procedures for CVC insertion followed
standard guidelines, i.e., use of maximal barrier precau-
tions, skin antisepsis and meticulous hand hygiene. Skin
antisepsis was performed with 0.5% chlorhexidine in 70%
alcohol (Cedium®, QUALIPHAR) or with 5% alcoholic
povidone-iodine (Iso-Betadine® solution hydroalcoolique,
MEDA Pharma). The same types of material were used in
each ICU. In particular, antimicrobial coated catheters,
antiseptic-impregnated catheters, chlorhexidine dressings
and patches were not used.
Two meetings of one hour per ICU were organized in
August 2011 to explain the study and remind the staff of
the evidence-based procedures known to decrease rates
of CLABSI. One meeting was held for medical and nurse
ICU heads, and one meeting was held for ICU staff. The
objectives proposed to the ICU staff were zero femoral
site use, at least 80% adherence with CVC-care recom-
mendations and a 50% decline in the CLABSI rate.
Throughout the study phase, the medical record of
every patient in the ICU for at least 48 hours and with
positive blood cultures was reviewed by each local infec-
tion control team using a common data collection form.
All positive blood cultures episodes were thereafter sub-
categorized locally as CLABSI, primary bloodstream in-
fection (BSI) (no CVC), secondary BSI, or contaminant.
Each case was reviewed by the investigator team.
The prevention program is fully described in Table 1.
During the intervention phase, no new CVC care proced-
ure was modified or implemented. Observations of adher-
ence with recommendations for CVC management were
performed randomly, usually during the higher-activity
phase of the day (offering the most opportunities to ob-
serve), once a week during 45–60 minutes in each ICU.
This external monitoring was assessed by the same trained
research nurse for all of P2. In addition, The ICU staffs
were aware that compliance with CVC insertion and main-
tenance practices was recorded. During audits of CVC
care, the ICU nurses were encouraged to modify their
practice when it appeared that their clinical practice was
inconsistent with accepted guidelines. During a monthly
meeting of approximately 20–30 minutes in each ICU, re-
ported performances were presented to support nurse staff
efforts and to promote accountability. Moreover, a monthly
Table 1 Description of the central line infection control program






Care process 1. Appropriate hand hygiene
before and after any CVC care
As baseline As baseline As baseline
2. Use of maximal barrier
precautions and skin
antisepsis (0.5% chlorhexidine
in 70% alcohol or alcoholic
povidone-iodine) before CVC
insertion
3. Replacement of gauze
dressing every 24 hours or
when damp, loose, or visibly
soiled replacement of
transparent dressings every
7 days or when damp, loose,
or visibly soiled
4. Disinfection of catheter
hubs and injection ports
before they are accessed
with an appropriate
antiseptic (chlorhexidine in
70% alcohol or 70% alcohol)
5. Traceability of information












Type of insertion site None Point prevalence survey





of type of insertion site as
in phase 1
Point prevalence survey
of type of insertion site as
in phase 1
Care process None None Monitoring of 5 CVC care
process. Compliance rate
with each care process
was calculated by
dividing the number of
actions performed by the
number of appropriate
actions, expressed as a
percentage
None
Staff meetings Two meetings of study
information and staff
education per ICU
None Monthly meeting with




Feedback reports None None Monthly feedback reports
of outcome and process
indicators posted in each




via e-mail to ICU leaders
Feedback posted in the
ICU at the ICU leaders’
discretion
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study investigator. Variations in nurse staffing, includ-
ing the percentage of staff turnover and percentage of
pool nurses were recorded. Data on the ICU physicians
and nurses’ participation at the monthly meetings orga-
nized during P2 and the percentage of feedback postedby the ICU staff throughout the ICU during P3 were
also collected.
Definitions
We used the definitions for BSIs of the Belgian surveil-
lance protocol corresponding to the 1998 CDC National
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CLABSI was defined as primary BSI with a central ven-
ous catheter present for the last 48 hours. Secondary
bacteremia was defined as BSI that developed as the re-
sult of a documented infection with the same micro-
organism at another site. The incidence density rate was
defined as number of CLABSI cases per 1,000 CVC-
days. For each phase, the total CLABSI incidence dens-
ity rate was calculated as the mean of monthly CLABSI
incidence density rates. The CVC-utilization ratio was
obtained by dividing the number of CVC-days by the
number of patient-days. If a patient had more than one
CVC, only one was counted.
Participation in feedback meetings was expressed for
nurses as a percentage (number of nurses present at
each meeting compared to the number of nurses in the
ICU in this phase) and for ICU physicians as a dichot-
omous variable (participation was considered as effective
if at least 2 physicians were present at each meeting).
Regular staff was defined as nurses permanently assigned
to the ICU (expressed in full-time equivalents). Pool staff
was defined as nursing staff who were employees of nurs-
ing agencies. Pool staff was assigned to the ICU for differ-
ent lengths of time. The staff turnover was defined as the
percentage of regular ICU nurses leaving the ICU between
the beginning and the end of the study.
The rate of feedback displayed during P3 was defined
as the number of posters displayed in the ICU over the
number of feedback reports addressed by the investiga-
tor team.
Statistical methods
The results are expressed as the median (interquartile
range) or as the mean (SD), as appropriate. Categorical
variables were assessed with a Chi-square test or Fisher’s
exact test when applicable. A Cochran-Mantel-Haenszel
test was used in the analysis of stratified categorical data.
As used in previous studies [9], and because CLABSI are
rare events, a Poisson regression analysis was used to gen-
erate an incidence-rate ratio (IRR) compared with pre-
intervention CLABSI incidence density rates. One-way
ANOVA test was applied to evaluate statistically signifi-
cant difference between the CVC-utilization ratios across
the different phases.
A 2-sided p-value < 0.05 was considered statistically
significant. All data analyses were performed using Stata
software, version 12.0 (StataCorp LP, College Station,
Texas, USA).
Ethical considerations
The institutional review boards at each hospital approved
the study protocol (number CE 2011/31 for Brugmann
University Hospital and number AK/11-03-31/4011 for
Saint Pierre University Hospital).Results
During the three study phases, there were 18,467 CVC-
days. There was no statistically significant difference of the
CVC-utilization ratio between the three phases (p = 0.679,
one-way ANOVA test) (Table 2).
Process indicators
Monitoring of process measures was performed during a
total of 111 hours. The rates of compliance with recom-
mendations for CVC insertion and maintenance are rep-
resented in Figure 1. Compliance with hand hygiene was
46% in the first month and increased significantly during
months 2 to 6 of P2 (Relative risk [RR], 1.80; 95% confi-
dence interval [CI]: 1.52-2.13, p < 0.001). Compliance with
CVC handling was 69% in month 1 and also increased sig-
nificantly (RR, 1.17; 95% CI: 1.03-1.33, p = 0.003) as did
compliance with CVC dressing (RR, 1.10; 95% CI: 1.05-
1.15, p < 0.001). The median percentage of compliance
during the 6 months of the interventional phase (inter-
quartile range) with recommendations for adequate CVC
care was distributed as follows: CVC insertion 100 (90–
100), hand hygiene 84 (46–93), CVC dressing 91 (83–94),
CVC handling 81 (69–89), and notification of CVC and
perfusions 90 (84–94). The median compliances for CVC
care were not significantly different between hospitals A
and B.
Microbiological features
In P1, 69% of microorganisms identified were Gram-
positive, followed by Gram-negative organisms (27%)
and fungi (4%). In P3, the same proportion of microor-
ganisms was Gram-positive (69%), Gram negative (25%)
and fungi (6%). In P2, 56% of microorganisms identified
were Gram-negative, followed by Gram-positive organ-
isms (38%) and fungi (6%). Most common organisms
identified in both three phases were Streptococcus species
and Enterococcus species accounted for over 50% of the
Gram-positive pathogens.
Outcomes indicators
During P2, a significant reduction in the overall CLABSI
incidence density rate was observed with an incidence
rate-ratio (IRR) of 0.49 (p = 0.043), and no change in the
rate of secondary bacteremias. There was a 32% CLABSI
incidence density rate reduction between P3 and P1, but
the difference was not significant with IRR of 0.67 (p =
0.212) (Table 2).
During P1, the CLABSI rates were 3.63 (1.47-5.79) and
4.54 (0.23-8.85) per 1,000 CVC-days in hospitals A and
B, respectively. Both hospitals presented reductions in
the CLABSI incidence density rates during P2 in com-
parison with P1:1.34 (0.10-2.59) with IRR of 0.38 (0.13-
1.05, p = 0.063) and 2.32 (0.04-4.68) with IRR of 0.63
(0.24-1.62, p = 0.333) in hospitals A and B, respectively.
Table 2 Primary BSI, Secondary BSI and CLABSI rates per each phase











1 1,354 7,604 6,045 0.79 ± 0.07 37 1 12 (1. 58) 24 [4.00 (1.94-6.06)]
2 1,571 7,882 6,399 0.80 ± 0.11 33 6 15 (1.90) 12 [1.81 (0.46-3.17)]
3 1,439 7,615 6,023 0.78 ± 0.10 44 0 28 (3.68) 16 [2.73 (1.17-4.29)]
Total 4,364 23,101 18,467 0.79 ± 0.09 114 7 55 (2.38) 52 [2.85 (1.97-3.72)]
*Incidence Rate Ratio (95% Confidence Interval) and p-value (Poisson regression).
In the phase 2 compared to phase 1: 0.49 (0.24-0.98), p = 0.043.
In the phase 3 compared to phase 1: 0.67 (0.36-1.26), p = 0.212.
In the phase 3 compared to phase 2: 1.37 (0.65-2.89), p = 0.413.
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density rate increased to 2.83 (1.32-4.35) in hospital A,
with IRR of 1.99 (0.68-5.81, p = 0.210) and remained
stable at 2.74 (0.58-6.05) in hospital B with IRR of 0.92
(0.31-2.73, p = 0.876).
The rate of femoral CVC-use decreased between P2
(11%) and P1 (22%; RR, 0.50; 95% CI: 0.31-0.83, p = 0.01)
and later increased between P3 (20%) and P2 (RR, 1.74;
95% CI: 1.06-2.87, p = 0.03). The numbers of femoral
CLABSI among the total estimated femoral CVC-days
were 7/1330, 3/704 and 3/1205 during P1, P2 and P3, re-
spectively. The decline in the CLABSI rate observed dur-
ing P2 in comparison with P1 was independent of the
insertion site (femoral or non-femoral; Cochran-Mantel-
Haenszel test, p = 0.054).
Organizational indicators
Comparative organizational parameters between hospi-
tals A and B are reported in Table 3. The hospital A dif-
fers significantly from hospital B by a higher variation in
nurses staffing, a higher nurses’ participation in the
monthly meetings and a higher percentage of feedbacks
reports posted in ICU during P3.Figure 1 Compliance of CVC care recommendations.Discussion
The objective of this study was to examine the effect on
CLABSI rate of an external monitoring of CVC care com-
pliance process with feedback aimed mainly at nurses.
The major role of ICU nurses in reducing CLABSI rates
was previously demonstrated with education programs
dedicated especially to nurses [4,5]. To optimize preven-
tion, it is now accepted that the “bundle” concept should
be implemented, including five simple interventions sup-
ported by strong scientific evidence for effectiveness: opti-
mal hand hygiene, chlorhexidine skin antisepsis, maximal
barrier precautions for CVC insertion, use of optimal in-
sertion sites, and prompt catheter removal [17]. This bun-
dle is currently being used in several countries. Numerous
studies have reported successful results after implementa-
tion of a continuous, multifaceted strategy based on these
measures [3-8,19]. In our study, compliance with insertion
recommendations (observed in the first month of P2) was
initially high, most likely because of previous sensitization
and use of CVC kits. More recent studies suggest an
added benefit from broadening prevention strategies to
include evidence-based best practices for central-line
maintenance [10,11]. We chose to also monitor post-
Table 3 Comparative analysis of organizational indicators
between hospital A and hospital B
Hospital A Hospital B p-value
Pool nurses 110 (13%) 41 (8%) 0.005
Staff nurse turnover 26% 9% 0.025
Nurse participation 115 (88%) 62 (61%) <0.001
Number of meetings with the
expected physicians participation
13 (72%) 5 (42%) 0.136
Number of feedback reports posted 16 (89%) 0 (0%) <0.001
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disinfection before use of any access points (hubs-con-
nectors-injection ports) and hand hygiene before CVC
contact. Our intervention resulted in a transient but sig-
nificant reduction in CLABSI rates and the median per-
centage of compliance with each procedure for CVC
care was greater than 80%. As demonstrated by Furuya
et al., the use of a CVC bundle is associated with lower
infection rates only when compliance is high [20]. On
the other hand, we observed no decrease in the CVC
utilization ratio, but we did not implement a program
focused on daily review of unnecessary catheters except
indirectly with the surveillance of CVC placement
dating. Finally, we achieved a significant decrease in
femoral access during P2, with limited effect on the
CLABSI rate. It is known that the risk of CLABSI varied
according to the site of central venous access [21]. But
we compared only femoral central venous access site to
non-femoral central venous access site without regard-
ing in details subclavian and internal jugular routes.
The difference of CLABSI incidence rate reduction ob-
served between P2 and P1 in hospitals A and B could be
explained by the significantly different participation of
nurses recorded in the monthly meetings, reflecting less
engagement at hospital B. We also observed a lack of
investment by the ICU physicians as represented by
their absence from the monthly meetings and the small
amount of feedback posted in the ICU during P3 in
hospital B. This may have influenced the outcome, as
the HCW in the last may be less professionally moti-
vated than the others. Ensuring staff understand the
change process is fundamental to the success of a qual-
ity improvement.
We observed a non significant reduction of CLABSI
incidence rate in P3 in comparison with P1, while Pro-
novost et al. [9] reported a sustained reduction of up to
66% in CLABSI rates after 18 months of follow-up in a
larger study with an educational intervention based
mainly on use of the CVC insertion bundle. Potentially,
the lack of individual face-to-face contact and feedback
maybe explains the lack of sustainability of our program,
as described in another study [22]. In that study, eachHCW was approached individually regarding the insertion
technique and maintenance of CVC and therefore felt
valued and motivated. Our approach involved collective
feedback through monthly and non-mandatory meetings.
Successful practice changes require buy-in from partici-
pants. Therefore, it is necessary to pay close attention to
perceived barriers. More research is needed to develop a
more direct measure of HCW engagement in quality and
safety.
Another explanation for the declining performance
during P3 could be the high turnover in nurse staffing
and the high percentage of pool nurses recorded, particu-
larly in hospital A. Robert et al. suggested in a case–control
study that nurse staffing composition (i.e., pool-nurse–to-
patient ratio) might be related to primary BSI risk [23]. In
our study, the monitoring of process indicators was termi-
nated at the end of P2, and in the following months, there
were no more clinical reminders for ICU staff. Moreover,
no specific training related to line care was planned for
pool staff. Based on our experience, account should be
taken of these structural parameters to adjust in further
studies the frequency of process measurements. Finally,
feedback alone (as done in P3) was ineffective for altering
provider behaviors.
There are a number of limitations to this study. First, it
is not a randomized trial, but a quasi-experimental study
without a concurrent control group, a design frequently
used for this type of study. Thus, other unmeasured fac-
tors, such as long-term trends or seasonal confounders
might have occurred coincident with the intervention
resulting in independent variations in CLABSI rates
[24]. Second, unmeasured factors such as patient risk
severity may have confounded CLABSI rates; however,
it is unlikely that the case composition would have
changed in the same manner during the intervention
phase in all 5 ICUs.Conclusions
Our encouraging results emphasized the value of this
intervention based on auditing and feedback to reinforce
practice changes to decrease CLABSI rates. This inter-
vention was dependant on local factors such as the lack
of leadership and support inside the ICU and the high
turnover of ICU nurses, as illustrated by the difference
observed between the 2 hospitals despite a targeted
compliance with CVC care recommendations achieved.
Our study underlines the need to monitor behavioral
parameters in addition to process and results indicators,
to analyze the benefits of any new infection control pro-
gram. Further studies are needed to determine which
strategies are most effective in changing professional be-
havior and in promoting long-term, sustained adherence
to evidence-based practices for CLABSI prevention.
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